- 专利标题: BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6
-
申请号: EP18730042.1申请日: 2018-05-25
-
公开(公告)号: EP3630291A1公开(公告)日: 2020-04-08
- 发明人: BELLENIE, Benjamin Richard , CARTER, Michael Keith , CHEUNG, Kwai Ming Jack , DAVIS, Owen Alexander , HOELDER, Swen , LLOYD, Matthew Garth , VARELA RODRÍGUEZ, Ana , WOODWARD, Hannah , INNOCENTI, Paolo
- 申请人: Cancer Research Technology Limited , The Institute of Cancer Research: Royal Cancer Hospital
- 申请人地址: 2 Redman Place London E20 1JQ GB
- 专利权人: Cancer Research Technology Limited,The Institute of Cancer Research: Royal Cancer Hospital
- 当前专利权人: Cancer Research Technology Limited,The Institute of Cancer Research: Royal Cancer Hospital
- 当前专利权人地址: 2 Redman Place London E20 1JQ GB
- 代理机构: HGF Limited
- 优先权: GB201708502 20170526; GB201806130 20180413
- 国际公布: WO2018215801 20181129
- 主分类号: A61P35/00
- IPC分类号: A61P35/00 ; C07D401/12 ; C07D403/12 ; C07D413/14 ; C07D403/14 ; C07D409/14 ; C07D417/14 ; A61K31/4184
公开/授权文献
- EP3630291B9 BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6 公开/授权日:2024-05-29
信息查询
IPC分类:
A | 人类生活必需 |
A61 | 医学或兽医学;卫生学 |
A61P | 化合物或药物制剂的特定治疗活性 |
A61P35/00 | 抗肿瘤药 |